170 related articles for article (PubMed ID: 498154)
1. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study.
Rossof AH; Talley RW; Stephens R; Thigpen T; Samson MK; Groppe C; Eyre HJ; Fisher R
Cancer Treat Rep; 1979; 63(9-10):1557-64. PubMed ID: 498155
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
[No Abstract] [Full Text] [Related]
4. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Fowler WC; Hatch K
Cancer Treat Rep; 1986 Sep; 70(9):1097-100. PubMed ID: 3755650
[TBL] [Abstract][Full Text] [Related]
5. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
Rossof AH; Coltman CA; Jones SE; Talley RW
Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
[TBL] [Abstract][Full Text] [Related]
7. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF
Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
[TBL] [Abstract][Full Text] [Related]
10. cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.
Dombernowsky P; Sörenson S; Aisner J; Hansen HH
Cancer Treat Rep; 1979 Apr; 63(4):543-5. PubMed ID: 221119
[No Abstract] [Full Text] [Related]
11. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].
Tominaga K; Saijo N; Eguchi K; Shinkai T; Shimizu E
Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
14. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.
Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH
Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
Wiltshaw E; Kroner T
Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
[TBL] [Abstract][Full Text] [Related]
18. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
[No Abstract] [Full Text] [Related]
19. Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy.
Bruckner HW; Cohen CJ; Wallach RC; Kabakow B; Deppe G; Greenspan EM; Gusberg SB; Holland JF
Cancer Treat Rep; 1978 Apr; 62(4):555-8. PubMed ID: 350392
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]